Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy

Background and purpose Generalized myasthenia gravis (gMG) continues to present significant challenges for clinical management due to an unpredictable disease course, frequent disease fluctuations, and varying response to therapy. The recent availability of new pharmacologic therapies presents a val...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of neurology Jg. 31; H. 6; S. e16180 - n/a
Hauptverfasser:	Saccà, Francesco, Salort‐Campana, Emmanuelle, Jacob, Saiju, Cortés‐Vicente, Elena, Schneider‐Gold, Christiane
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England John Wiley & Sons, Inc 01.06.2024
Schlagworte:	Algorithms Availability Biomarkers classification Cost of Illness Decision making disease burden generalized myasthenia gravis Health services Human motion Humans Immune system Immunosuppressive agents Myasthenia gravis Myasthenia Gravis - drug therapy Myasthenia Gravis - therapy Neuromuscular junctions pathophysiology Patients Quality of Life Social impact targeted therapy targeted therapy disease burden classification generalized myasthenia gravis pathophysiology
ISSN:	1351-5101, 1468-1331, 1468-1331
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!